Press
MedGenome’s OncoMD helps analyze Genetic Alterations in Mesothelioma – Paper published in Nature Genetics
Mesothelioma is a relatively rare cancer with a five year survival rate between five and ten percent. The global death due to Mesothelioma is estimated to be ~43,000 per year.
Considering Genomic Research?
Company
Resources
Research
- Tumor Microenvironment Solutions
- Immune Profiling Services
- NGS Services
- BioFX Bioinformatics Services
- Antibody Discovery Services
Diagnostics
Contact
2023 © MedGenome • All Rights Reserved